| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $70.66M | $36.60M | $32.49M | $13.90M | $21.49M |
| R&D | $57.65M | $20.71M | $21.86M | $5.59M | $13.85M |
| SG&A | $12.41M | $15.41M | $10.62M | $8.30M | $7.63M |
| Operating Income | -$70.66M | -$36.60M | -$32.49M | -$13.90M | -$21.49M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $1.04M | $0.00 | – | – | – |
| Net Income | -$69.38M | -$35.48M | -$31.48M | -$13.88M | -$21.71M |
| EPS (basic) | -4.7100 | -12.1700 | -1.0000 | -0.8000 | -1.5500 |
| EPS (diluted) | -4.7100 | -12.1700 | -1.0000 | -0.8000 | -1.5500 |
| Shares (diluted) | – | – | – | $17.38M | $13.97M |